Other Clinical Trial - Efficacy & Safety of the Administration of

Efficacy and Safety of the Administration of Ondansetron Versus Habitual Clinical Practice for the Treatment of Vomiting in Children With Mild and Moderate Dehydration: Randomized Clinical Trial

Vomiting in Infants and/or Children Clinical Trial

Official title:
Efficacy and Safety of the Administration of Ondansetron Versus Habitual Clinical Practice for the Treatment of Vomiting in Children With Mild and Moderate Dehydration: Randomized Clinical Trial

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT01492569` - Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting	N/A
Completed	`NCT05076461` - Ondansetron Versus Domperidone for Treating Vomiting in Acute Gastroenteritis in Children	N/A
Recruiting	`NCT03118986` - RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy	Phase 2

See also

Status

Clinical Trial

Phase

Withdrawn

NCT01492569 - Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting

N/A

Completed

NCT05076461 - Ondansetron Versus Domperidone for Treating Vomiting in Acute Gastroenteritis in Children

N/A

Recruiting

NCT03118986 - RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04318847
Study type	Interventional
Source	Basque Health Service
Contact	Lizar Aguirre Pascasio, Dr
Phone	945007374
Email	LIZAR.AGUIRREPASCASIO@osakidetza.eus
Status	Not yet recruiting
Phase	Phase 4
Start date	October 10, 2021
Completion date	April 10, 2023

Efficacy and Safety of the Administration of Ondansetron Versus Habitual Clinical Practice for the Treatment of Vomiting in Children With Mild and Moderate Dehydration: Randomized Clinical Trial

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms